>Brookings Oregon News, Sports, & Weather | The Curry Coastal Pilot

News Classifieds Web
web powered by Web Search Powered by Google

News arrow News arrow Business arrow CHETCO PHARMACY AND GIFTS WINS AWARD

CHETCO PHARMACY AND GIFTS WINS AWARD Print E-mail
August 05, 2008 11:00 pm

Chetco Pharmacy, a member of Health Mart, the nation's fastest-growing independent pharmacy franchise, has been selected as a regional winner of McKesson's 2008 Pharmacy of the Year award.

McKesson's annual awards program recognizes leading independent pharmacies for the exceptional healthcare contributions they have made to their communities over the past 12 months.

McKesson selected the regional award winners based on performance against several key criteria, including: customer educational programs, use of technology to increase efficiencies and ensure accuracy, product selection, in-store programs and design, local marketing and advertisement and community involvement.

"Our regional pharmacy of the year award winners consistently provide patients with excellent customer service. Through hard work and dedication to their customers, award winners exemplify why Health Mart was recently ranked No. 1 in customer satisfaction nationwide," said Tim Canning, president, Health Mart. "It's an honor to congratulate all of our regional award winners for their commitment to delivering the highest level of pharmaceutical care."

"At Chetco Pharmacy, our number one priority is to always exceed the expectations of our customers," said Tim Yantis, RPh and owner of Chetco Pharmacy. "As an independent pharmacy, we're faced with an increasingly competitive marketplace, but one that is also ripe with great opportunity for growth. McKesson and Health Mart have partnered with us every step of the way, providing us with the resources to create a best-in-class pharmacy that our customers can count on for the highest level of personal attention. We're thrilled to be named a Pharmacy of the Year."

Yantis, a native Oregonian, has served as the full-time pharmacist for Chetco Pharmacy for the last 11 years and has worked at the pharmacy for the last 28 years. Chetco Pharmacy is a second-time recipient of the Pharmacy of the Year award having also won in 2005.

Chetco Pharmacy has 21 employees who provide the community of Brookings with consistent and excellent patient care.

 

Business News by Yahoo Finance

  • Pfizer mulls $100 billion bid for AstraZeneca: report
    U.S. pharmaceutical giant Pfizer (PFE) has approached British rival AstraZeneca (AZN.L) to propose a 60 billion pound ($101 billion) takeover, the Sunday Times reported on Sunday. The paper said, citing senior investment bankers and industry sources, that informal conversations about a deal had taken place between the two firms but that no talks were currently under way after AstraZeneca resisted the approach. AstraZeneca is Britain's second-biggest pharmaceuticals group with a current market valuation of around $80 billion, compared with Pfizer, which is valued at $193 billion, according to Thomson Reuters data. Earnings at AstraZeneca fell 6 percent in the fourth quarter of 2013, and the drugmaker has said it expects them to keep falling in 2014 as generic competition to Nexium, its popular heartburn and ulcer drug, takes a big bite out of U.S. profits from late May.
  • Wall Street Week Ahead: Spring fever brings hope for U.S. earnings
    Several behemoths, including Apple, the largest U.S. company by market value, as well as Microsoft, McDonald's (MCD.N) and AT&T (NYS:T), are due to report earnings. They'll be accompanied by highfliers like Netflix and Facebook, giving the first real cross-section of the state of corporate America as temperatures rise across the country and investors hope to put the cold weather behind them. Strategists will also be looking for clues on how badly China's slowdown hits U.S. corporate results. The first batch of earnings came out as equities were working their way through a selloff led by trading-crowd favorites like Netflix and the biotech stocks.
  • GM to invest $12 billion in China and plans more plants
    U.S. car giant General Motors Corp (GM) (GM) plans to invest $12 billion in China from 2014 to 2017 and build more plants next year as it steps up its presence to compete with aggressive rivals in the world's largest auto market. GM expects its China sales to expand 8-10 percent this year, in line with the overall growth of the Chinese market, where foreign firms, such as Volkswagen AG (VOW3.DE), and domestic players like SAIC Motor Corp vie for more market share. In total we are investing $12 billion between 2014 and 2017," Matt Tsien, president of GM China, said at the Auto China show in Beijing. GM plans to build five more plants in China next year, as part of its efforts to ramp up manufacturing capacity there by 65 percent by 2020, executives said on Sunday.

Follow Curry Coastal Pilot headlines on Follow Curry Coastal Pilot headlines on Twitter

© Copyright 2001 - 2014 Western Communications, Inc. All rights reserved. By Using this site you agree to our Terms of Use